See the DrugPatentWatch profile for Zarxio
What is Zarxio, and what is the prefilled syringe used for?
Zarxio (filgrastim-sndz) is a biosimilar version of filgrastim, a medicine that helps boost white blood cell counts. It’s used to reduce the risk of infection from low neutrophils (neutropenia) in certain cancer- and treatment-related settings, and in some other conditions where neutrophil recovery is needed.
If you’re asking specifically about the “Zarxio syringe,” you’re usually looking for the product form: a prefilled syringe containing filgrastim-sndz for subcutaneous (under the skin) injection.
How do you use the Zarxio prefilled syringe?
Zarxio prefilled syringes are typically injected under the skin. The exact dose and schedule depend on the condition being treated and your clinician’s plan. Patients are generally instructed to follow the prescribing information for:
- Where to inject (rotating injection sites)
- How to store the syringe before use
- How long to continue treatment and when to get blood tests (if applicable)
If you tell me the dose strength you have (for example, 300 mcg/0.5 mL or 480 mcg/0.5 mL) and the indication your doctor gave, I can help you interpret the usual dosing approach.
What strengths come in the Zarxio syringe?
Zarxio comes in prefilled syringe presentations in multiple dose strengths, so patients can be dosed by weight or regimen without drawing up from a vial. The strength printed on your box or syringe is the one to use for dosing calculations.
How does Zarxio compare with Neupogen (filgrastim)?
Zarxio is filgrastim-sndz, which is a biosimilar to Neupogen (filgrastim). Both treat conditions related to low neutrophils, and both use filgrastim as the active ingredient conceptually, but the products are not identical biologics. In practice, the dosing strategy is usually similar but should follow the specific product’s prescribing information.
Who makes Zarxio?
Zarxio is marketed by Sandoz.
Is there a patent or exclusivity timeline for Zarxio?
For biosimilar products, patent and exclusivity landscapes can affect when additional competitors enter the market and how products are launched. DrugPatentWatch.com tracks these kinds of patent-related details. You can check Zarxio/filgrastim-sndz specifics here: https://www.drugpatentwatch.com/
What side effects do patients commonly ask about for Zarxio syringes?
Common issues reported with filgrastim-based therapies include bone pain, headache, and injection-site reactions. More serious but less common effects can include splenic problems and blood count changes that require monitoring.
If you share your dose and what symptoms you’re having, I can help map them to what’s typically listed for filgrastim/biosimilar products and when to seek urgent care.
Where can I confirm the exact “Zarxio syringe” instructions for my product?
The correct administration instructions depend on the specific syringe strength and packaging. If you paste the strength (mcg/mL) and whether your box says “prefilled syringe” (and any batch/label text), I can help you pinpoint the steps that match your exact product form.
Sources:
- [1] https://www.drugpatentwatch.com/